Back
Catalyst Pharmaceuticals Vs. Expedia Group Industry Stock Comparison
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
16.50
Seasonality Move:
16.98%
Sell
48
EXPE
Expedia Group
Last Price:
113.98
Seasonality Move:
8.66%
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $16.49. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
48
Expedia Group (EXPE)
is a Sell
Is Expedia Group a Buy, Sell or Hold?
- The current Expedia Group [EXPE] share price is $114.01. The Score for EXPE is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
- EXPE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $16.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
EXPE Stock Price Chart
What is Expedia Group's stock price today?
-
The Expedia Group share price today is $114.01
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EXPE is experiencing slight buying pressure.
CPRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.28 | Buy |
Relative Strength Index (14 RSI): | 61.13 | Buy |
Chaikin Money Flow: | -382725 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.82 - 16.04) | Buy |
Bollinger Bands (100): | (14.24 - 16.32) | Buy |
EXPE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.51 | Sell |
Relative Strength Index (14 RSI): | 32.68 | Sell |
Chaikin Money Flow: | 1004127 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (114.28 - 134.18) | Sell |
Bollinger Bands (100): | (125.67 - 148.45) | Sell |
CPRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 16.07 | Buy |
20-day SMA: | 15.42 | Buy |
50-day SMA: | 15.68 | Buy |
200-day SMA: | 14.37 | Buy |
8-day EMA: | 16.14 | Buy |
20-day EMA: | 15.73 | Buy |
50-day EMA: | 15.49 | Buy |
200-day EMA: | 14.73 | Buy |
EXPE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 112.87 | Buy |
20-day SMA: | 123.1 | Sell |
50-day SMA: | 129.38 | Sell |
200-day SMA: | 125.89 | Sell |
8-day EMA: | 114.63 | Sell |
20-day EMA: | 120.08 | Sell |
50-day EMA: | 127.21 | Sell |
200-day EMA: | 126.93 | Sell |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
Expedia Group Earnings Growth & EXPE Earnings Dates
- Analysts estimate an earnings increase this quarter of $1.46 per share, a decrease next quarter of $2.62 per share, an increase this year of $2.12 per share, and an increase next year of $2.83 per share.
Catalyst Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Expedia Group Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |